ERCC2 and adenoma: Our results indicate that the XPD Lys751Gln polymorphism may predispose slightly to development of colorectal adenomas or that the polymorphism may be of importance for arresting the adenoma-carcinoma sequence in the low-risk phase and facilitate regression of adenomas.